<DOC>
	<DOCNO>NCT01127204</DOCNO>
	<brief_summary>The MONOD trial aim evaluate implementation early antiretroviral treatment strategy HIV-infected infant assess feasibility efficacy simplify initial propose regimen successful one year treatment . The initial treatment AZT-3TC-LPV/r twice day . After one year , child randomize one following : arm 1-reference AZT-3TC-LPV/r twice daily ; arm 2-simplified ABC-3TC-EFV daily . The perspective project identify antiretroviral strategy improve treatment access adherence child sub-saharian Africa .</brief_summary>
	<brief_title>Evaluation Simplified Antiretroviral Treatment Strategies HIV Infected Children Treated Antiretroviral ( ARV ) Before One Year Age</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Inclusion Criteria antiretroviral treatment initiation : infant followup one trial site HIV1 infection diagnose RT PCR 6 week life age 3 12 month antiretroviral treatment initiation naive antiretrovirals except receive prevention mother child HIV transmission HB &gt; =7 g/dl , neutrophile &gt; 750/mm3 , creatinin &lt; 3xULN , TGO TGP &lt; 3xULN sign inform consent Exclusion Criteria antiretroviral treatment initiation : HIV2 infection HIV1/HIV2 coinfection Known intolerance one trial treatment HB &lt; 7 g/dl , neutrophile &lt; 750/mm3 , creatinin &gt; 3xULN , TGO TGP &gt; 3xULN Inclusion Criteria randomisation 12 month simplification phase : age 24 month virological success define 2 consecutive indetectable HIV RNA measure RT PCR least 3 month apart . Exclusion Criteria randomisation 12 month simplification phase : virological failure first 12 month antiretroviral treatment</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>HIV</keyword>
	<keyword>Antiretroviral therapy</keyword>
	<keyword>Infant</keyword>
	<keyword>Sub Saharian Africa</keyword>
</DOC>